S

Sophia Genetics SA
NASDAQ:SOPH

Watchlist Manager
Sophia Genetics SA
NASDAQ:SOPH
Watchlist
Price: 3.31 USD 1.53% Market Closed
Market Cap: 216.4m USD
Have any thoughts about
Sophia Genetics SA?
Write Note

Sophia Genetics SA
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sophia Genetics SA
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
S
Sophia Genetics SA
NASDAQ:SOPH
PP&E Net
$23.1m
CAGR 3-Years
61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascom Holding AG
SIX:ASCN
PP&E Net
CHf10.6m
CAGR 3-Years
18%
CAGR 5-Years
7%
CAGR 10-Years
-3%
No Stocks Found

Sophia Genetics SA
Glance View

Market Cap
219.9m USD
Industry
Health Care

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.

SOPH Intrinsic Value
4.3 USD
Undervaluation 23%
Intrinsic Value
Price
S

See Also

What is Sophia Genetics SA's PP&E Net?
PP&E Net
23.1m USD

Based on the financial report for Dec 31, 2023, Sophia Genetics SA's PP&E Net amounts to 23.1m USD.

What is Sophia Genetics SA's PP&E Net growth rate?
PP&E Net CAGR 3Y
61%

Over the last year, the PP&E Net growth was 8%. The average annual PP&E Net growth rates for Sophia Genetics SA have been 61% over the past three years .

Back to Top